PROAmgen Inc
stock417.57
+2.70 (+0.65%)
Price as of 13 Oct, 13:36 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Bullish
2 bull · 1 bear · 2 neutral
Medium-Term Outlook
Bullish
4 bull · 0 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD above signal line
%K below %D
Price near middle band
Volatility measure — informational only
Market Statistics
Day Change
+2.70
Market Cap
140B
Exchange
NYSE
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Amgen Inc
What is Amgen Inc?
Amgen Inc. is one of the world's largest independent biotechnology companies, specializing in the research, development, and manufacturing of human therapeutics. The company focuses on treating serious illnesses in areas such as oncology, cardiovascular disease, and bone health by using advanced molecular biology and biochemistry.
Is Amgen Inc a good investment?
Amgen is often considered a steady performer known for its consistent dividend payments and strong portfolio of established drugs, though it faces risks like patent expirations and high costs associated with drug development. Investors should weigh the potential for innovation against regulatory pressures and market competition, keeping in mind that this information is for educational purposes and not financial advice.
How do you invest in Amgen Inc?
You can invest in Amgen by purchasing shares directly through a regulated brokerage platform that provides access to the NASDAQ exchange. Alternatively, you may gain exposure by investing in exchange-traded funds or mutual funds that include the healthcare or biotechnology sectors as part of their holdings.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for AMGN — be the first to start the discussion.
Point & Figure Analysis
Famous Investors Holding AMGN
Ken Fisher
1.59M sh · 0.2% of portfolio
$575.61M
NEW
Ken Griffin
918.1K sh · 0.0% of portfolio
$332.46M
NEW
Ken Griffin
582.8K sh · 0.0% of portfolio
$211.03M
NEW
Ken Griffin
497.3K sh · 0.0% of portfolio
$180.08M
NEW
Ken Griffin
350.0K sh · 0.0% of portfolio
$126.74M
NEW
Ken Griffin
121.2K sh · 0.0% of portfolio
$43.89M
NEW
Ray Dalio
21.9K sh · 0.0% of portfolio
$7.92M
NEW
Mario Gabelli
4.6K sh · 0.0% of portfolio
$1.67M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.